Key statistics
As of last trade Compass Pathways PLC (5Y6:FRA) traded at 4.88, -28.76% below its 52-week high of 6.85, set on Nov 04, 2025.
52-week range
| Open | 4.86 |
|---|---|
| High | 4.88 |
| Low | 4.86 |
| Bid | 5.40 |
| Offer | 5.80 |
| Previous close | 4.88 |
| Average volume | 811.71 |
|---|---|
| Shares outstanding | 96.02m |
| Free float | 45.30m |
| P/E (TTM) | -- |
| Market cap | 557.86m USD |
| EPS (TTM) | -2.68 USD |
Data delayed at least 15 minutes, as of Feb 16 2026 08:55 GMT.
More ▼
Press releases
- Compass Pathways to Announce New Clinical Data from Two Ongoing Phase 3 Trials
- Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD
- Compass Pathways Establishes Strategic Collaboration with Radial to Innovate Patient Experience and Inform Potential Delivery Model of COMP360
- Compass Pathways to Host Webinar on Commercial Preparations for Treatment-Resistant Depression (TRD) and Clinical Trial Plans for Post-Traumatic Stress Disorder (PTSD) on January 7, 2026, 10:00am ET
- Compass Pathways to Participate in Two Investor Conferences in December
More ▼
